申请人:[en]VICTORIA LINK LIMITED
公开号:WO2022260535A1
公开(公告)日:2022-12-15
Compounds of the Formula (I), pharmaceutical compositions comprising compounds of the Formula (I), and their use for treating or preventing an infection caused by Human Cytomegalovirus (HCMV), Epstein-Barr virus (EBV), or Human Immunodeficiency Virus (HIV).